Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed that it enclosed a press today titled ‘Indoco Remedies receives USFDA approval for Lacosamide Tablets’.
The above information is a part of company’s filings submitted to BSE.